DIA 2020 Virtual Global Annual Meeting has ended

Create Your Own Event

DIA 2020 Virtual Global Annual Meeting

arrow_back View All Dates

8:00am EDT

#100 SL: DIA Global Annual Meeting – Opening DIAmond and Plenary Session TBD

10:15am EDT

#101 SL-CH: Challenges in Advanced Therapy Development: A New Community TBD #102 SL-IT: Advanced Clinical Innovation Theater: Future Forward Trends for Overcoming the Talent Shortage in Clinical Research while Diminishing Risk TBD #103 SL-IT: Veeva Innovation Theater: Annual Industry Report - Trends, Insights, and Strategies to Modernize Clinical Operations TBD #104 SL-IT: ArisGlobal Innovation Theater: Leveraging Automation in PV TBD

11:00am EDT

#105 SL: To Shape the Future of Patient Labeling Across Regions TBD #106 SL: Clinical Trials in a Digital Age: A Modern Approach to an Outdated Model TBD #107 L: Patients First! How FDA is Making Patients a Priority TBD #108 SL: Leveraging Clinical Pharmacology to Transform Real World Data into Real World Evidence for Special Patient Populations TBD #109 L: International Convergence on Regulatory Review and HTA: Getting the “Universal Evidence” We Need for Decisions on Innovation TBD #110 L: Outcomes as a Pathway to Value and Pharma, Payer, Provider Collaboration TBD

12:00pm EDT

#601 NL: Networking Lounge: Real World Evidence TBD #602 NL: Networking Lounge: COVID-19 TBD #603 NL: Networking Lounge: Patient Focused TBD #604 NL: Networking Lounge: Emerging Professionals and Students TBD #605 NL: Networking Lounge: Advanced Therapies TBD #607 NL: Networking Lounge: Digital Technology and Artifical Intelligence TBD #608 NL: Networking Lounge: Data Science TBD #608.1 NL: Networking Lounge: Diversity, Disparities, and Inclusiveness TBD

12:30pm EDT

#111 SL-CH: Collecting Meaningful Patient Experience Data TBD #113 SL-IT: Google Innovation Theater: Enabling Insights and Collaboration Across the Lifesciences Enterprise with Google Cloud and Accenture TBD #115 SL-IT: IQVIA Innovation Theater: COVID-19 Disruption Provides a Pivotal Opportunity to Accelerate Patient Engagement Innovation TBD #116 SL-IT: Parexel Innovation Theater: The Future is Now: The Rise and Rise of Decentralized Clinical Trials During the COVID Pandemic and Beyond TBD #112 L-RT: Round Table Discussion: Patients First! How FDA is Making Patients a Priority TBD

1:00pm EDT

#117 SL-IT: Syneos Health Innovation Theater: Patient Engagement: Driving Better Care and Outcomes TBD #118 SL-IT: WCG Innovation Theater: A Tale of Two Eras: Interpreting Clinical Operations Data Pre- and Post- COVID-19 TBD #118.1 SL-IT: UBC Innovation Theater: Unlocking the Evidence-Generating Potential of the EMR TBD

1:30pm EDT

#119 L: How Do You Oversee and Manage New Centralized/Remote/Site Monitoring Models? What Should you Measure to Gain Insights? TBD #120 L: The Changing Role of the Data Professional TBD #121 SL: Non-Profit Organizations Role in Accelerating Preclinical Compound Testing to Fuel the Rare Disease Clinical Pipeline TBD #122 L: ICH 30th Anniversary Series: Harmonizing Global Requirements for Clinical Trials TBD #123 L: Is Your App a Drug, a Device, or Something Else Entirely? TBD #124 SL: Gene Therapy Manufacturing: How Can Innovation Help Overcome This Anticipated Hurdle? TBD

2:30pm EDT

#125 SL-IT: Covance Innovation Theater: Driving Patient-Centric Trials: Moving Beyond the Hype TBD #126 SL-IT: SAS Innovation Theater: The Role of Augmented Clinical Trials in the Response to COVID-19 and Beyond TBD #127 SL-IT: IQVIA Innovation Theater 2: Digital Patient Orchestration, An Examination of the Patient Journey TBD

3:00pm EDT

#128 SL-IT: Appian Innovation Theater - Bayer: Shaping the Future to Meet Our Needs – A Digital Transformation TBD

3:30pm EDT

#129 SL: The Rare Disease Clinical Outcome Assessment Consortium: Aiming to Fulfill Unmet Drug Development Endpoint Measurement Needs TBD #130 L: Virtual Clinical Trials TBD #131 L: Engaging Patients to Support the Modernization of ClinicalTrials.gov TBD #132 SL: Benchmarking and Identifying Opportunities to Improve Intentional Dose Non-Adherence in Clinical Trials TBD #133 L: FDA’s Considerations on Benefit-Risk Assessment for Human Drug Review TBD #134 L: Should a COVID-19 Vaccination be Legally Mandated and Can HTA Inform That Decision? TBD